Dama, Azzubayn A.

HRN: 21-45-57  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/07/2022
06/13/2022
IV
88mg
Q6hrs
Age With Mod Dhn; Abscess Right Mastoid T/c Sepsis
Waiting Final Action 
06/08/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
06/08/2022
06/15/2022
IVT
17mg
Q24H
Occipital Abscess
Waiting Final Action 
06/08/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/08/2022
06/15/2022
IVT
35mg
Q8H
Occipital Abscess
Waiting Final Action 
06/08/2022
CEFTRIAXONE 1G (VIAL)
06/08/2022
06/15/2022
IV DRIP
165mg
Q12
Abscess Right Mastoid; T/c Sepsis
Waiting Final Action 
06/12/2022
MUPIROCIN 2%, 15G (TUBE)
06/12/2022
06/18/2022
TOPICAL
2%
Bid
Infected Wound R Mastoid Area
Waiting Final Action 
06/13/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/13/2022
06/20/2022
IV DRIP
250mg
Q6H
Sepsis, Abscess Right Mastoid Area
Waiting Final Action 
07/05/2022
CEFIXIME 100MG/5ML, 60ML SUSPENSION (BOT)
07/05/2022
07/11/2022
PO
1.7ml
Q12
Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: